JNJ — Johnson & Johnson Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual cashflow statement for Johnson & Johnson, fiscal year end - December 29th, USD millions except per share, conversion factor applied.

	2021 January 3rd	2022 January 2nd	2023 December 31st	2023 January 1st	2024 December 29th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	14,714	20,878	35,153	17,941	14,066
Depreciation
Deferred Taxes
Non-Cash Items	42	1,459	-18,161	1,957	3,207
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital	2,690	-4,238	2,507	-4,011	1,837
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	23,536	23,410	22,791	21,194	24,266
Capital Expenditures	-3,347	-3,652	-4,543	-4,009	-4,424
Purchase of Fixed Assets
Other Investing Cash Flow Items	-17,478	-5,031	5,421	-8,362	-14,175
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-20,825	-8,683	878	-12,371	-18,599
Financing Cash Flow Items	-627	395	-1,602	65	-736
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-6,120	-14,047	-15,825	-8,871	-3,132
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-3,320	502	7,732	-360	2,246